Improving HIV treatment for mobile men in Malawi
Official title: Reducing Mobility-associated Interruption in ART among Men in Malawi (ReMIT)
Funded at University of California Los Angeles · NIH-11009453 · Data updated 2026-11-12
This study is looking to help men living with HIV in Malawi who move around a lot by testing a new way to make it easier for them to stick to their medication, which includes getting their meds for several months at once, having a special hotline for support, and personalized counseling to address their specific needs.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $183,179 |
| NIH project number | 1K01MH138243-01 |
| Project ID | NIH-11009453 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are men living with HIV in Malawi who frequently move for work or other reasons and struggle to maintain their treatment regimen.
✕Less likely to help
Patients who are not mobile or those who do not have access to ART services may not benefit from this research.
What this research studies
This research focuses on enhancing the retention of antiretroviral treatment (ART) among mobile men living with HIV in Malawi. It aims to develop and test an intervention that includes multi-month dispensing of medication, a dedicated hotline for support, and counseling tailored to the unique challenges faced by these individuals. By gathering insights from patients, healthcare workers, and community members, the study seeks to create a more effective care model that accommodates the mobility of these men. A pilot trial will assess the intervention's effectiveness and feasibility in real-world settings.
Why it matters
Potential benefit: If successful, this research could significantly improve ART retention and health outcomes for mobile men living with HIV.
How similar studies have gone: Previous research has shown that tailored interventions can improve treatment adherence among marginalized populations, suggesting potential success for this approach.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Thorp, Marguerite — University of California Los Angeles
- Study coordinator: Thorp, Marguerite
Related research
Other NIH-funded projects on the same topics.
-
Understanding how genetic changes in blood cells relate to heart disease in people with HIV
A study will look at how age-related blood cell mutations and large chromosomal changes might contribute to heart disease risk in people living with HIV.
-
Systems genetics of vascular smooth muscle phenotypes in heart disease
Aims to understand how genetic differences influence vascular smooth muscle cells to improve prevention and treatment of coronary artery disease.
-
Motivation for Alcohol Use in Humans and How It Can Be Measured
This grant explores how people are motivated to drink alcohol and tests a safe, controlled way to study that motivation to inform better treatments for alcohol use disorder.
-
Overcoming CAR T cell resistance with tumor-targeted IL-12 to boost anti-tumor immunity
Aims to make CAR T cell therapy work better for solid tumors by using tumor-focused IL-12 to boost the body’s attack on cancer.
-
PediCODE: A Biorepository and Consortium for CoDE - Congenital Diarrhea and Enteropathy
A nationwide effort to collect clinical data and patient-derived samples to uncover the genetic causes of congenital diarrhea and enteropathy and to build a resource that helps researchers study these diseases.
-
Mentor Moms+: a community-led plan to cut alcohol use and HIV risk during pregnancy in South Africa
A community-based program adapts a trusted peer-led model to help pregnant and lactating people reduce alcohol use and HIV risk in South Africa.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.